BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24798621)

  • 1. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction.
    Cortes M; Pareja E; García-Cañaveras JC; Donato MT; Montero S; Mir J; Castell JV; Lahoz A
    J Hepatol; 2014 Sep; 61(3):564-74. PubMed ID: 24798621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of real-time metabolomics in liver transplantation: Graft evaluation and donor-recipient matching.
    Faitot F; Besch C; Battini S; Ruhland E; Onea M; Addeo P; Woehl-Jaeglé ML; Ellero B; Bachellier P; Namer IJ
    J Hepatol; 2018 Apr; 68(4):699-706. PubMed ID: 29191459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.
    Zhu Z; Tang Y; Huang S; Zhao Q; Schroder PM; Zhang Z; Zhang Y; Sun C; Wang L; Ju W; Wang D; Guo Z; He X
    Clin Transplant; 2018 Dec; 32(12):e13438. PubMed ID: 30383902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor age and outcome of liver transplantation.
    Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
    Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids analysis: a tool to assess graft function in human liver transplantation.
    Vilca Melendez H; Rela M; Setchell KD; Murphy GM; Heaton ND
    Transpl Int; 2004 Jul; 17(6):286-92. PubMed ID: 15205724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.
    Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.
    Deschênes M; Forbes C; Tchervenkov J; Barkun J; Metrakos P; Tector J; Alpert E
    Liver Transpl Surg; 1999 Sep; 5(5):357-61. PubMed ID: 10477834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Yang L; Xin EY; Liao B; Lai LJ; Han M; Wang XP; Ju WQ; Wang DP; Guo ZY; He XS
    Transplant Proc; 2017; 49(6):1357-1363. PubMed ID: 28736007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early outcomes of liver transplants in patients receiving organs from hypernatremic donors.
    Khosravi MB; Firoozifar M; Ghaffaripour S; Sahmeddini MA; Eghbal MH
    Exp Clin Transplant; 2013 Dec; 11(6):537-40. PubMed ID: 23534482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.
    Palombo JD; Burke PA; Moldawer LL; Forse RA; Lewis WD; Jenkins RL
    J Am Coll Surg; 1994 Aug; 179(2):209-19. PubMed ID: 7519108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated proteomics and metabolomics approach to assess graft quality and predict early allograft dysfunction after liver transplantation: a retrospective cohort study.
    Lin Y; Huang H; Cao J; Zhang K; Chen R; Jiang J; Yi X; Feng S; Liu J; Zheng S; Ling Q
    Int J Surg; 2024 Jun; 110(6):3480-3494. PubMed ID: 38502860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.
    Lee DD; Singh A; Burns JM; Perry DK; Nguyen JH; Taner CB
    Liver Transpl; 2014 Dec; 20(12):1447-53. PubMed ID: 25179581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No difference in clinical transplant outcomes for local and imported liver allografts.
    Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chestovich P; Milgrom ML; Kazimi M; Hollinger EF; Read JT; Tector AJ
    Liver Transpl; 2009 Jun; 15(6):640-7. PubMed ID: 19479808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction.
    Xu J; Casas-Ferreira AM; Ma Y; Sen A; Kim M; Proitsi P; Shkodra M; Tena M; Srinivasan P; Heaton N; Jassem W; Legido-Quigley C
    Sci Rep; 2015 Dec; 5():17737. PubMed ID: 26635289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.